OTC •
Healthcare •
Biotechnology •
Quote as of 06/17/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization0.8414 mln
Float30.64 mln
Earnings Date08/28/2025
Piotroski F-Score
3
/ 9
Below average
Relative Strength
2
/ 100
Severely lagging
Debt / Equity
-0.10
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Payout Ratio
0%
No payout
Business Description
Agentix Corp. is a US-based medical research company working to develop new treatments for conditions such as obesity, type 2 diabetes, and fatty liver disease. Its two lead drug candidates, AGTX-2004 and AGTX-2003, have both shown promising results in animal studies and work by targeting a specific receptor in the body linked to metabolic function. Founded in 2020 and headquartered in Dana Point, California, the company was previously known as FairWind Energy Inc. before shifting its focus to healthcare in June 2019.
